tiprankstipranks
Trending News
More News >

Portfolio #1 - New Portfolio

Portfolio #1
Individual Investor
Ranked #419,367 out of 832,956 TipRanks' Investors
Success Rate
35%
234 out of 678
profitable transactions
Average Return
31.69%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.28%
6-Month Return▲ 78.06%
12-Month Return▲ 91.88%
YTD Return▲ 86.29%
Total Return▲ 405.72%

Best Trade

Opened at
Closed at-
Gain▲ 6500.00%

Bio

General portfolio. I have a private one which I am more active in

Performance

19.30%0-19.30%
▲ 11.63%
▲ 6.28%
▲ 4.90%
May 2025
▲ 9.25%
▲ 5.14%
▲ 6.06%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 11.88%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 19.30%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 7.91%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 7.92%
Oct 2025
▼ 3.57%
▲ 0.19%
▲ 12.80%
Nov 2025
▼ 1.11%
▼ 1.75%
▲ 0.57%
Dec 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 11.63%▲ 6.28%▲ 4.90%
▲ 9.25%▲ 5.14%▲ 6.06%
▲ 7.60%▲ 2.30%▲ 11.88%
▲ 2.76%▲ 2.05%▲ 19.30%
▲ 12.88%▲ 3.56%▲ 7.91%
▲ 10.96%▲ 2.38%▲ 7.92%
▼ 3.57%▲ 0.19%▲ 12.80%
▼ 1.11%▼ 1.75%▲ 0.57%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Milestone Pharmaceuticals
0%
▼ 2.27%
1
Open
Dec 16, 2025
NexGel Inc
0%
▲ 15.24%
1
Open
Dec 16, 2025
AC Immune SA
0%
▼ 10.64%
1
Open
Dec 16, 2025
CASI Pharmaceuticals
0%
▼ 4.32%
1
Open
Dec 16, 2025
Agape ATP
0%
▲ 55.56%
1
Open
Dec 16, 2025
Contineum Therapeutics, Inc. Class A
0%
▼ 0.61%
1
Open
Dec 16, 2025
Enliven Therapeutics
0%
▼ 5.26%
1
Open
Dec 16, 2025
EyePoint Pharmaceuticals
0%
▼ 21.49%
3
Open
Dec 15, 2025
Tenaya Therapeutics
0%
▼ 16.31%
1
Open
Dec 15, 2025
Legend Biotech
0%
▼ 2.68%
1
Open
Dec 15, 2025
Aardvark Therapeutics, Inc.
0%
▼ 8.64%
1
Open
Dec 15, 2025
Ascendis Pharma
0%
▼ 4.89%
1
Open
Dec 15, 2025
Dyne Therapeutics
0%
▼ 3.52%
1
Open
Dec 15, 2025
Kyverna Therapeutics, Inc.
0%
▼ 36.14%
1
Open
Dec 15, 2025
Theravance Biopharma
0%
▼ 1.43%
1
Open
Dec 12, 2025
Cabaletta Bio
0%
▼ 1.27%
1
Open
Dec 12, 2025
Adicet Bio
0%
▼ 5.62%
1
Open
Dec 12, 2025
Larimar Therapeutics
0%
▼ 14.57%
1
Open
Dec 12, 2025
Connect Biopharma Holdings
0%
▼ 10.00%
1
Open
Dec 12, 2025
Neumora Therapeutics, Inc.
0%
▼ 15.31%
1
Open
Dec 12, 2025